WHO recommended collaborative TB/HIV activities: Evaluation of implementation and performance in a rural district hospital in Cameroon

Pan African Medical Journal

Volumn 10, Issue , 2011, Pages

  Yumo, Habakkuk Azinyui ^a   Kuaban, Christopher ^b,c   Neuhann, Florian ^d  

^a MINISTRY OF PUBLIC HEALTH   (Cameroon)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c Jamot Hospital   (Cameroon)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cameroon; District; Health facility; HIV; Implementation; Performance; Rural; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID; TUBERCULIN;

ADOLESCENT; ADULT; CAMEROON; CHILD; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PREVALENCE; PUBLIC HOSPITAL; REVIEW; RURAL AREA; SCHOOL CHILD; SEX DIFFERENCE; TUBERCULIN TEST; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 84862256993     PISSN: 19378688     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Corbett EL, Watt CJ, Phil D, Walker N, Maher D, Williams BG et al. The growing burden of tuberculosis- Global trends and interaction with the HIV epidemic. Arch Intern Med. 2003; 163:1009-1021. This article on PubMed
2. Boon NA, Colledge NR, Walker BR, Hunter J. Davidson's principles and Practice of Medicine. 20th Ed. Edinburgh. Churchill Livingstone. 695-702
3. Bucher HC, Griffith LE, Guyatt GH, Sudre P, Naef M et al. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS. 1999;13:501-507. This article on PubMed
4. Di Perri G, Cruciani M, Danzi MC, Luzzati R, De Checchi G, Malena M et al. Nosocomial epidemic of active tuberculosis among HIVinfected patients. Lancet. 1989; 2(8678-8679):1502-1504. This article on PubMed
5. Daley CL, Small PM, Schecter GF, Scoolink GK, McAdam RA, Jacobs WR, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992; 326:231-235. This article on Pub Med
6. Mukadi YD, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS. 2001;15(2):143-52. This article on PubMed
7. Egger M. Outcome of antiretroviral therapy in resource-limited and industrialized countries. Conference on Retroviruses and Opportunistic Infections (CROI) 2007, Los Angeles USA. Abstract 62. Available at: http://vih-sida.hug-ge.ch/publications/CROI_2007.pdf. Accessed on June 2010
8. World Health Organization. Global Tuberculosis Control: WHO Report 2010. ISBN 9789241564069. Available at: http://www.who.int/tb/publications/global_report/en/. Accessed 28 December 2010
9. Maher D, Harries A, Getahun H. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and program mes; implications for policies. Trop Med Int Health. 2005 Aug;10(8):734-742. This article on PubMed
10. Friedland G, Harries A, Coetzee D. Implementation Issues in Tuberculosis/HIV Program Collaboration and Integration: 3 Case Studies. J Infect Dis. 2007 Aug 15;196 Suppl 1:S114-S123. This article on PubMed
11. Martinot A, Van Rie A, Mulangu S, Mbulula M, Jarrett N, Behets F et al. Baseline assessment of collaborative tuberculosis/HIV activities in Kinshasa, the Democratic Republic of Congo. Tropical Doctor. 2008; 38 (3): 137-141. This article on Pub Med
12. World Health Organization. Interim policy on collaborative TB-HIV activities. Geneva, Switzerland: WHO/HTM/TB/2004.330; WHO/HTM/HIV/2004.1.WHO, 2004. Available at: http://www.who.int/tb/publications/tbhiv_interim_policy/en/index.html. Accessed May2010
13. World Health Organization. A guide to monitoring and evaluation for collaborative TB-HIV activities. WHO/HTM/TB/2009.414;WHO/HTM/HIV/09.01. Geneva, Switzerland: WHO, 2009. Available at: http://www.who.int/hiv/pub/tb/hiv_tb_monitoring_guide.pdf. Accessed June 2010
14. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global Report. UNAIDS Report on the Global AIDS Epidemic 2010. Geneva, Switzerland. UNAIDS 2010. Available at: http://www.unaids.org/documents/20101123_GlobalReport_Foreword_em.pdf. Accessed December 2010
15. World Health Organization. Networking for Policy Change: TB/HIV Advocacy Training Manual. Geneva, Switzerland. Stop TB Partnership WHO 2007. Available at: http://whqlibdoc.who.int/hq/2007/WHO_HTM_TB_2007.384a_eng.pdf. Accessed September 2010
16. Ministy of Public Health, Cameroon (2006) National Tuberculosis Control Programme. Manual for Health Personnel. Yaoundé, Cameroon. 2006 Edition
17. Ministry of Public Health. National. Guidelines for Management of People Living with HIV/AIDS, District Hospital Level. Yaounde, Cameroon. 1st Edition, June 2005
18. National AIDS Control Committee (NACC). Evaluation Report of the HIV/AIDS National Strategic Plan 2006-2010. Yaoundé, Cameroon. NACC 2010
19. Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, Chimzizi R, et al. The HIV-associated tuberculosis epidemic-when will we act?. Lancet. 2010; 375:1906-19. This article on PubMed
20. Harries AD, Zachariah R, Lawn SD. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa. Int J Tuberc Lung Dis. 2009 Jan;13(1):6-16. This article on Pub Med
21. Yumo HA, Mbanya D, Kuaban C, Neuhann F. Outcome Assessment of a Global Fund Grant in Tuberculosis Control at District Hospital Level in Rural Cameroon. Int J Tuberc Lung Dis. 2011; 15(3):352-357. This article on Pub Med
22. Yumo HA, Angwafor SA, Ayuk EM, Ndang CA. Opt in versus routine opt out approach in HIV testing: lessons learned from a rural district Hospital in North Western Cameroon. XVIIth International AIDS Conference 2008, Mexico. Abstract no. E11662. Available at: http://www.iasociety.org/Default.aspx?search=Yumo+HA&pageId=7. Accessed November 2010
23. Mwinga A, Mwananyambe N, Kanene C, Bulterys M, Phiri C, Kapata N et al. Provider-Initiated HIV Testing and Counseling of TB Patients- Livingstone District, Zambia, September 2004--December 2006. MMWR Morb Mortal Wkly Rep. 2008 Mar 21;57(11):285-289. This article on Pub Med
24. Gunneberg C, Reid A, Williams BG, Floyd K, Nunn P. Global monitoring of collaborative TB-HIV activities. Int J Tuberc Lung Dis. 2008 Mar;12(3 Suppl 1):2-7. This article on PubMed
25. Harries AD. Robert Koch Memorial Lecture- Robert Koch and the discovery of the tubercle bacilus: the challenge of HIV and tuberculosis 125 years later. Int J Tuberc Lung Dis. 2008; 12:241:249. This article on PubMed
26. Sume GE, Etogo D, Kabore S, Gnigninanjouena O, Epome SS, Metchendje JN. Sero prevalence of Human Immunodeficiency Virus Infection among tuberculosis patients in the Nylon District Hospital Tuberculosis Treatment Centre. East Afr Med J. 2008; 85:529-536.This article on PubMed
27. National Institute of Statistics Cameroon. Demographic and Health Survey (DHS). Yaoundé, Cameroon. 2004
28. Kuaban C, Bercion R, Koulla Shiro S. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free antituberculosis treatment in Yaounde, Cameroon. East Afr Med J. 1997; 74(8):474-477. This article on PubMed
29. World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resourceconstrained settings. Department of HIV/AIDS. Stop TB Department